×
Join our live online event
How top hedge funds use news to make money
form the stock market & how ordinary people are
copying their strategies
Register now!
form the stock market & how ordinary people are
copying their strategies
No thanks
GLTO – galecto, inc. (US:NASDAQ)
DELAYED
$
| Volume Shares | |
| 1 Day Range | |
| Volume Ratio | |
| 52 Week High | |
| 52 Week Low |
| VWAP | |
| Today’s Volatility | |
| 20 Days Volatility | |
| Open | |
| Prior Close |
1D
5D
1M
3M
YTD
1Y
3Y
1 Day
GLTO
SPY
QQQ
Swipe to see more
Main News & Impact Reports
Date
Time
Symbol
Headline
Impact
11/14
11:31 am
glto
Galecto (GLTO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
Low
Report
Galecto (GLTO) May Find a Bottom Soon, Here's Why You Should Buy the Stock Now [Yahoo! Finance]
11/1
08:30 am
glto
Galecto Reports Third Quarter 2024 Financial Results
Low
Report
Galecto Reports Third Quarter 2024 Financial Results
10/17
09:39 am
glto
Galecto, Inc. (NASDAQ: GLTO) had its price target raised by analysts at Oppenheimer Holdings Inc. from $9.00 to $10.00. They now have an "outperform" rating on the stock.
Low
Report
Galecto, Inc. (NASDAQ: GLTO) had its price target raised by analysts at Oppenheimer Holdings Inc. from $9.00 to $10.00. They now have an "outperform" rating on the stock.
10/15
08:30 am
glto
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
Medium
Report
Galecto Strengthens Board of Directors with Appointment of Dr. Amy Wechsler
10/7
08:58 am
glto
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines [Yahoo! Finance]
Low
Report
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines [Yahoo! Finance]
10/7
08:45 am
glto
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines
High
Report
Galecto Completes Strategic Review to Focus on Oncology and Liver Disease and Acquires Acute Myeloid Leukemia Preclinical Asset from Bridge Medicines
Date
Time
Symbol
Company Name
Action
%Chg
Date
Time
Symbol
Headline
Impact
11/7
03:08 pm
glto
Form SC 13G/A Galecto, Inc. Filed by: Sunstone Life Science Ventures A/S
Medium
Report
Form SC 13G/A Galecto, Inc. Filed by: Sunstone Life Science Ventures A/S
11/7
02:56 pm
glto
Form SC 13G Galecto, Inc. Filed by: Sunstone Life Science Ventures A/S
Medium
Report
Form SC 13G Galecto, Inc. Filed by: Sunstone Life Science Ventures A/S
11/1
08:01 am
glto
Form 10-Q Galecto, Inc. For: Sep 30
Low
Report
Form 10-Q Galecto, Inc. For: Sep 30
10/15
04:15 pm
glto
Form 4 Galecto, Inc. For: Oct 11 Filed by: WECHSLER AMY B
Low
Report
Form 4 Galecto, Inc. For: Oct 11 Filed by: WECHSLER AMY B
10/15
04:00 pm
glto
Form 3 Galecto, Inc. For: Oct 11 Filed by: WECHSLER AMY B
Low
Report
Form 3 Galecto, Inc. For: Oct 11 Filed by: WECHSLER AMY B
10/15
09:15 am
glto
Form 8-K Galecto, Inc. For: Oct 15
Medium
Report
Form 8-K Galecto, Inc. For: Oct 15
10/11
05:00 pm
glto
Form 4 Galecto, Inc. For: Oct 09 Filed by: Kronmiller Matthew
Medium
Report
Form 4 Galecto, Inc. For: Oct 09 Filed by: Kronmiller Matthew
10/11
05:00 pm
glto
Form 4 Galecto, Inc. For: Oct 09 Filed by: Schambye Hans T.
Medium
Report
Form 4 Galecto, Inc. For: Oct 09 Filed by: Schambye Hans T.
Stock Stats
| News Stats | |
|---|---|
| All News | |
| News Wires | |
| Media Monitoring | |
| SEC Edgar Filings | |
| Upgrades | |
| Downgrades | |
| Initiated | |
| Reiterated | |
| Last Earnings | |
| Last Earnings EPS | |
| Next Earnings | |
| Order Stats |
|---|
| Sub-Penny |
|
|
| Odd lot |
|
|
| Avg. bid-ask spread |
|
|
| Avg. bid-ask size |
|
|
| Shares at ask/bid |
|
|
| Off exchange |
|
|
Main News & Impact Reports
TOP News Gainers
TOP News Decliners
Don’t Miss Out On The Next BIG Stock Move
Never get left behind with our daily ‘Shakers & Movers’ newsletter. Discover the biggest gainer or loser in the stock market, and learn exactly WHY it moved. To find out which one caught Wall Street by surprise TODAY, sign up to our newsletter below: